Papadaki, M.A.; Mala, A.; Merodoulaki, A.C.; Vassilakopoulou, M.; Mavroudis, D.; Agelaki, S.
Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate. Cancers 2022, 14, 3903.
https://doi.org/10.3390/cancers14163903
AMA Style
Papadaki MA, Mala A, Merodoulaki AC, Vassilakopoulou M, Mavroudis D, Agelaki S.
Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate. Cancers. 2022; 14(16):3903.
https://doi.org/10.3390/cancers14163903
Chicago/Turabian Style
Papadaki, Maria A., Anastasia Mala, Aikaterini C. Merodoulaki, Maria Vassilakopoulou, Dimitrios Mavroudis, and Sofia Agelaki.
2022. "Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate" Cancers 14, no. 16: 3903.
https://doi.org/10.3390/cancers14163903
APA Style
Papadaki, M. A., Mala, A., Merodoulaki, A. C., Vassilakopoulou, M., Mavroudis, D., & Agelaki, S.
(2022). Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate. Cancers, 14(16), 3903.
https://doi.org/10.3390/cancers14163903